Middlesbrough, United Kingdom

Christopher Reeve

This inventor holds 1 USPTO granted patent. Top assignee: Astra Aktiebolag. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Reeve. Retrieved from https://idiyas.com/inventor/christopher-reeve

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher Reeve: Innovator in Pharmaceutical Compounds

Introduction

Christopher Reeve is a notable inventor based in Middlesbrough, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of pharmaceutically active compounds through biooxidation. His innovative work has led to the granting of one patent, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Reeve holds a patent for the "Preparation of pharmaceutically active compounds by biooxidation." This patent reflects his commitment to developing new methods for creating effective pharmaceutical products, which can have a profound impact on healthcare.

Career Highlights

Reeve is currently associated with Astra Aktiebolag, a leading company in the pharmaceutical industry. His role at Astra allows him to collaborate with other talented professionals and contribute to groundbreaking research and development in the field.

Collaborations

Throughout his career, Reeve has worked alongside esteemed colleagues such as Stephen Taylor and Robert Holt. These collaborations have further enriched his work and have been instrumental in driving innovation within the pharmaceutical sector.

Conclusion

Christopher Reeve's contributions to the field of pharmaceuticals through his patent and work at Astra Aktiebolag highlight his role as an innovator. His dedication to advancing medical science is evident in his research and collaborations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…